Delayed Total Mesorectal Excision After Rectal-Sparing Strategies, Oncologic Safety and Surgical Outcomes: a Propensity Score–Matched Study from ReSARCh trial

2026-07-07

PRE

Quoc Riccardo Bao

Alessandra Pulvirenti *

Carlotta Parati

Giulia Battisti

Paolo Delrio

Angelo Restivo

Giuditta Chiloiro

Claudio Coco

Paola Del Bianco

Maria Antonietta Gambacorta

Daniela Rega

Gaya Spolverato

DOI：10.1016/j.ejso.2026.111965

Original

Original request for help

Save

Abstract

En 中文

In rectal cancer patients managed with rectal-sparing after neoadjuvant chemoradiotherapy (nCRT), total mesorectal excision (TME) is recommended in selected cases, such as local regrowth, recurrence, or high-risk histopathological features. However, the oncologic impact of delayed TME remains unclear. This study aimed to assess whether delayed TME compromises oncologic outcomes and increases postoperative complications.

Delayed Total Mesorectal Excision After Rectal-Sparing Strategies, Oncologic Safety and Surgical Outcomes: a Propensity Score–Matched Study from ReSARCh trial

Abstract

Journal

Organization

Cited Papers

Citing Papers